Amentoflavone, a Preferentially TGF-β Receptor 1 Inhibitor, Alleviates Cardiac Remodeling and Dysfunction Through Modulating the TGF-β/Smad and MAPK Signaling Pathways.

Wu J et al.

NCBI PubMed Central · Papers · License: Open Access

computer science education

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160000
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.